The largest database of trusted experimental protocols

15 protocols using heparin vacutainers

1

Whole Blood and Platelet Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was collected by venipuncture into either heparin vacutainers (BD, Franklin Lakes) for whole blood experiments or acid-citrate-dextrose (ACD) vacutainers (BD, Franklin Lakes) for platelet isolation studies. For platelet isolation, samples were supplemented with apyrase (Sigma, St Louis) and prostaglandin E1 (Cayman Chemical, Ann Arbor) and PRP was prepared by centrifugation of the ACD whole blood for 20 min at 200×g. Platelets were isolated from the PRP by centrifugation for 10 min at 1000×g and re-suspended in modified Tyrode’s buffer twice at desired platelet counts and kept at 37 °C until used. Isolated platelets were used within 2 h of preparation.
+ Open protocol
+ Expand
2

SARS-CoV-2 Vaccine Immunogenicity Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood was collected by standard phlebotomy. Blood collection occurred at baseline, approximately one week after first vaccination (“Post 1st dose”), prior to the second vaccination (“Pre 2nd dose”), approximately one week after the second vaccination (“Post 2nd dose”), and one month after the second vaccination (“One month post 2nd dose”), as depicted in Fig. 1A. PBMCs were isolated from heparin vacutainers (BD Biosciences) that were stored overnight at room temperature, followed by processing using Sepmates (STEMCELL Technologies) in accordance with the manufacturer’s recommendations. Serum was collected in SST tubes (BD Biosciences) and frozen immediately at −80°C.
+ Open protocol
+ Expand
3

Isolation of NK Cells from Breast Cancer Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood of patients with breast cancer and healthy donors was directly obtained in heparin vacutainers, BD Biosciences, San Jose, CA, USA. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood using lymphocyte separation medium, Lonza Walkersville, Inc. Houston TX, USA. The cell pellet was washed twice in calcium- and magnesium-free Dulbecco’s PBS-2% FCS-2 mM EDTA, enumerated on a haemocytometer with trypan blue and resuspended at 5 × 107/500 μl. NK cells were isolated through immunomagnetic negative selection using Dynabeads® Untouched™ Human NK Cells kit, Invitrogen Cergy-Pontoise, France, following the manufacturer’s recommendations. The purity (% of CD3CD56+) of NK cells measured by flow cytometry confirmed that these cells were more than 98% CD3CD56+ NK cells and less than 2% CD3+.
+ Open protocol
+ Expand
4

Longitudinal Assessment of Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood was collected by standard phlebotomy. Blood collection occurred at baseline, approximately one week after first vaccination (“Post 1st dose”), prior to the second vaccination (“Pre 2nd dose”), approximately one week after the second vaccination (“Post 2nd dose”), and one month after the second vaccination (“One month post 2nd dose”), as depicted in Fig. 1A. Peripheral blood mononuclear cells (PBMC) were isolated from heparin vacutainers (BD Biosciences) that were stored overnight at room temperature (RT), followed by processing using Sepmates (Stem Cell, Inc) in accordance with the manufacturer’s recommendations. Serum was collected in SST tubes (BD Biosciences) and frozen immediately at −80°C.
+ Open protocol
+ Expand
5

Blood Sampling and PBMC Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood was collected by standard phlebotomy. Blood collection occurred at baseline, approximately one week after first vaccination (“Post 1st dose”), prior to the second vaccination (“Pre 2nd dose”), approximately one week after the second vaccination (“Post 2nd dose”), and one month after the second vaccination (“One month post 2nd dose”), as depicted in Fig. 1A. PBMCs were isolated from heparin vacutainers (BD Biosciences) that were stored overnight at room temperature, followed by processing using Sepmates (STEMCELL Technologies) in accordance with the manufacturer’s recommendations. Serum was collected in SST tubes (BD Biosciences) and frozen immediately at -80°C.
+ Open protocol
+ Expand
6

Plasma Isolation and Neutrophil Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to prepare plasma, blood was collected in 3 ml blood tubes (Roche) containing recombinant hirudin (15 µg/ml) from four healthy volunteers. After centrifugation for 10 min at 2080g plasma was collected, pooled and stored at -80°C. For the isolation of human neutrophils, blood from a healthy donor was collected in heparin vacutainers (BD) and cells were isolated using the Ficoll-Histopaque gradient method (Bestebroer et al. 2007 (link)).
+ Open protocol
+ Expand
7

Reconditioning of Decellularized Vein Grafts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three of the five DC pig veins and three DC human veins were reconditioned.
One of the human veins was split and reconditioned with blood from
two different donors. Before the reconditioning of the ECM, frozen
DC veins were thawed at room temperature or 4 °C overnight. Human
vein femoralis were examined for valve direction to decide on the
flow in blood reactors. All veins were connected to ligands before
the reconditioning started.
Reconditioning of veins with whole
blood has previously been described by Håkansson et al.18 (link) Briefly, 30–50 mL of whole blood from
human or pig donors were collected in heparin vacutainers (BD). The
blood was mixed with STEEN solution (XVIVO Perfusion) 1:1 and 0.5%
AA (Thermo Fisher). The vascular endothelial growth factor (VEGF,
80 ng/mL, Bio-Techne) and fibroblast growth factor 2 (FGF2, 10 ng/mL,
CellGenix) were added to the solution together with 5 μg/mL
acetylsalicylic acid (Sigma-Aldrich) to prevent thrombosis. Glucose
levels were monitored and adjusted to 3–8 mM during the entire
perfusion process (Figure 7). After 7 days, veins were washed, and samples were sent
for proteomics analysis. The blood used for reconditioning was species-specific
to the vein segment.
+ Open protocol
+ Expand
8

Whole Blood IFN-I Response Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
pDC IFN-I was measured via whole blood stimulation as previously published (22 (link)). Briefly, blood was collected immediately following vaccination directly into heparin vacutainers (BD, Franklin Lakes, NJ, USA) containing R10 + Brefeldin A + CL097 and maintained at 37°C in a dry block heater during laboratory transport before further incubation up to 6 hours, red blood cell (RBC) lysis, and staining for flow cytometry via LSR II (flow cytometry antibodies are detailed in Supplementary Table S3).
+ Open protocol
+ Expand
9

Isolation of Human PBMCs from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

Whole blood (Stanford Hospital Blood Center, Stanford, Calif.) was collected from individual or mixed donors (depending on the amount of blood required) in 10 mL Heparin vacutainers (Becton Dickinson). Approximately 10 ml of whole anti-coagulated blood was mixed with sterile phosphate buffered saline (PBS) buffer for a total volume of 20 ml in a 50 ml centrifuge tube (PBS, pH 7.4, without Ca+2 and Mg+2). The blood/PBS (20 ml) was layered on top of 15 mL of Ficoll-Paque PLUS (GE Healthcare) in a conical centrifuge tube gently, and the sample was centrifuged at 400×g for 30-40 min at room temperature. The layer of cells containing peripheral blood mononuclear cells (PBMC) at the diluted plasma/Ficoll interface was removed, washed, and centrifuged at 200×g for 10 min at room temperature. Cells were counted with a hemocytomter. The PBMC were washed once with CAR-T media (AIM V-AlbuMAX(BSA) (Life Technologies), with 5% AB serum and 1.25 μg/mL amphotericin B (Gemini Bioproducts, Woodland, Calif.), 100 U/mL penicillin, and 100 μg/mL streptomycin) and used for experiments or were frozen at −80° C.

+ Open protocol
+ Expand
10

PBL-Derived RNA Isolation and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The materials and methods used to isolate and purify PBL-derived RNA from all 16 animals have been described by us previously. Briefly, whole blood was collected from each animal in 8 ml heparin vacutainers® (Becton-Dickinson Ltd., Dublin, Ireland) and RNA extraction was performed within 2 h of blood collection. The complete methods used for blood collection, PBL isolation, and total RNA extraction and purification have been described by us previously (12 (link)). RNA quantity and quality checking was performed using the NanoDrop™ 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and the Agilent 2100 Bioanalyzer using an RNA 6000 Nano LabChip kit (Agilent Technologies, Cork, Ireland). All samples displayed a 260/280 ratio >1.8 and RNA integrity numbers (RIN) >8.0.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!